Literature DB >> 27896404

En Bloc Resection with Major Blood Vessel Reconstruction for Locally Invasive Retroperitoneal Paragangliomas: A 15-Year Experience with Literature Review.

Hankui Hu1, Bin Huang1, Jichun Zhao2, Ding Yuan1, Yi Yang1, Fei Xiong1.   

Abstract

BACKGROUND: Retroperitoneal paragangliomas (PGs) are a rare subgroup of neuroendocrine tumors that are commonly located alongside the abdominal aorta. Complete tumor resection is thought to be restricted in patients with major blood vessel involvement. However, no study has specifically focused on aggressive surgical treatment in such patients. We evaluated the value of en bloc resection with major blood vessel reconstruction for locally invasive retroperitoneal PGs.
METHODS: Twenty-nine patients with retroperitoneal PGs with major blood vessel involvement were included in this retrospective study. Survival was compared between patients who underwent en bloc resection with major blood vessel reconstruction and those who underwent medical treatment. Prognostic predictors were analyzed in patients who underwent en bloc resection with major blood vessel reconstruction.
RESULTS: All 11 patients who underwent medical treatment obtained a pathological diagnosis by computed tomography-guided percutaneous needle biopsy. All 18 patients who underwent en bloc resection with major blood vessel reconstruction achieved complete tumor resection. Overall survival was higher in patients who underwent complete tumor resection than in those who underwent medical treatment (p < 0.05). No perioperative mortality occurred in patients who underwent complete tumor resection. Patients with no metastasis, no organ invasion, R0 resection, a Ki-67 index of ≤3%, and a tumor diameter of ≤11.7 cm showed better tumor-free survival (p < 0.05).
CONCLUSIONS: En bloc resection with major blood vessel reconstruction can be successfully performed and provide satisfactory outcomes for patients with locally invasive retroperitoneal PGs. This technique may become a standard surgical strategy for properly selected patients.

Entities:  

Mesh:

Year:  2017        PMID: 27896404     DOI: 10.1007/s00268-016-3846-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  18 in total

1.  Extra- adrenal silent retroperitoneal paraganglioma: report of a rare case.

Authors:  Hemalatha A L; Avadhani Geeta K; Anoosha K; Ashok K P; M Rajani Deepa
Journal:  J Clin Diagn Res       Date:  2014-11-20

2.  Outcomes of resection of extra-adrenal pheochromocytomas/paragangliomas in the laparoscopic era: a comparison with adrenal pheochromocytoma.

Authors:  Trudie A Goers; Michael Abdo; Jeffrey F Moley; Brent D Matthews; Mary Quasebarth; L Michael Brunt
Journal:  Surg Endosc       Date:  2012-08-31       Impact factor: 4.584

3.  Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas.

Authors:  Martin K Walz; Klaus Peitgen; Hartmut P H Neumann; Onno E Janssen; Thomas Philipp; Klaus Mann
Journal:  World J Surg       Date:  2002-06-06       Impact factor: 3.352

4.  The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.

Authors:  Herbert Chen; Rebecca S Sippel; M Sue O'Dorisio; Aaron I Vinik; Ricardo V Lloyd; Karel Pacak
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

5.  A decade of clinical experience with extra-adrenal paragangliomas of retroperitoneum: Report of 67 cases and a literature review.

Authors:  Jin Wen; Han-Zhong Li; Zhi Gang Ji; Quan Zhong Mao; Bing Bing Shi; Wei Gang Yan
Journal:  Urol Ann       Date:  2010-01

6.  Consensus guidelines for the management and treatment of neuroendocrine tumors.

Authors:  Pamela L Kunz; Diane Reidy-Lagunes; Lowell B Anthony; Erin M Bertino; Kari Brendtro; Jennifer A Chan; Herbert Chen; Robert T Jensen; Michelle Kang Kim; David S Klimstra; Matthew H Kulke; Eric H Liu; David C Metz; Alexandria T Phan; Rebecca S Sippel; Jonathan R Strosberg; James C Yao
Journal:  Pancreas       Date:  2013-05       Impact factor: 3.327

7.  Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas.

Authors:  Laurence Amar; Eric Baudin; Nelly Burnichon; Séverine Peyrard; Stéphane Silvera; Jérôme Bertherat; Xavier Bertagna; Martin Schlumberger; Xavier Jeunemaitre; Anne-Paule Gimenez-Roqueplo; Pierre-François Plouin
Journal:  J Clin Endocrinol Metab       Date:  2007-07-24       Impact factor: 5.958

8.  Predictive characteristics of malignant pheochromocytoma.

Authors:  Junsoo Park; Cheryn Song; Myungchan Park; Sangjun Yoo; Se Jun Park; Seokjun Hong; Bumsik Hong; Choung-Soo Kim; Hanjong Ahn
Journal:  Korean J Urol       Date:  2011-04-22

9.  Laparoscopic resection of an interaortocaval paraganglioma: diagnosis following a needle biopsy.

Authors:  Joshua B Brewster; Chandru P Sundaram
Journal:  JSLS       Date:  2007 Oct-Dec       Impact factor: 2.172

Review 10.  Pheochromocytoma and paraganglioma: imaging characteristics.

Authors:  Juan C Baez; Jyothi P Jagannathan; Katherine Krajewski; Kevin O'Regan; Katherine Zukotynski; Matthew Kulke; Nikhil H Ramaiya
Journal:  Cancer Imaging       Date:  2012-05-07       Impact factor: 3.909

View more
  1 in total

1.  Successful emergency endovascular aortic repair for intratumoral hemorrhage in extensive retroperitoneal mass of testicular origin.

Authors:  S Hulova; R Aziri; I Vulev; P Palacka; G Kolnikova; K Rejlekova; M Chovanec; J Mardiak; D Pindak; M Mego
Journal:  BMC Surg       Date:  2020-11-07       Impact factor: 2.102

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.